CREB3L1 and breast carcinoma: To explore these additional pathways, we segregated breast cancers that have active PERK signaling into two categories according to the expression level of CREB3L1 (CREB3L1-high and CREB3L1-low, respectively), and employed gene set enrichment analysis (GSEA) to compare these two cohorts (Fig. 5c).